Beranda › Anemia
Uji klinis Anemia yang merekrut di AS
29 studi untuk Anemia merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY7 studi
- Atlanta, GA6 studi
- Miami, FL6 studi
- Philadelphia, PA6 studi
- Tampa, FL5 studi
- Houston, TX5 studi
- St. Louis, MO4 studi
- Winston-Salem, NC4 studi
- Cleveland, OH4 studi
- Baldwin Park, CA4 studi
- Gilbert, AZ3 studi
- Seattle, WA3 studi
- Portland, OR3 studi
- Edison, NJ3 studi
- Los Angeles, CA3 studi
- Nashville, TN3 studi
- The Woodlands, TX3 studi
- Queens, NY3 studi
- Washington, DC3 studi
- Orlando, FL3 studi
Berdasarkan negara bagian
- Arizona4 studi
- California8 studi
- Florida9 studi
- Georgia7 studi
- Maryland3 studi
- Minnesota3 studi
- Missouri6 studi
- New Jersey3 studi
- New York11 studi
- North Carolina5 studi
- Ohio6 studi
- Oregon3 studi
- Pennsylvania7 studi
- Tennessee4 studi
- Texas7 studi
- Washington3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07623161Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05320198Study of DISC-0974-201 in Participants With IBD and Anemia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07368972A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07422480A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06499285A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Menerima pesertaStudi observasional
1 Month – 100 Years · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06092346T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Menerima pesertaFase 1/2
Usia 5 hingga 40 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Menerima pesertaFase 3
Usia 2 hingga 18 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06934967Choline and Iron Deficiency
Menerima pesertaFase 2/3
5 Months – 7 Months · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06527391Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07224360A Study of Luspatercept in People With Anemia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07725497Kids With Iron Deficiency and Scoliosis
Menerima pesertaSukarelawan sehat diterima
Usia 10 hingga 26 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06042699Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
Menerima pesertaStudi observasional
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT06106269131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Menerima pesertaFase 1
Usia 12 hingga 50 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT07015684Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Menerima pesertaFase 2
3 Days · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT05340465Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT05800600Therapeutic RSK1 Targeting in Myelofibrosis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT07379125Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT07281781A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT03893045Diamond Blackfan Anemia Registry (DBAR)
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT00106015Luspatercept for Clonal Cytopenias of Uncertain Significance
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06788691Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 18 Feb 2026 · NCT06979492The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT06606119129Xe MRI Cardiopulmonary
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT06038630A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Des 2025 · NCT05735314Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.